Promising immunotherapy uses cancer-killing cells to destroy malignant tumors

Promising immunotherapy uses cancer-killing cells to destroy malignant tumors - Blog, Cancer immunotherapy

CAR-T cell therapy, which received FDA approval in 2017, are highly effective against some blood-borne cancers and offer significant benefits but are not uniformly applicable to all forms of cancer. In addition, in patients with solid tumors, T cells can cause devastating and even fatal side effects. That’s why researchers at McMaster University have developed […]